{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "CNS", "aromatherapy", "essential oils", "nanomedicine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35009027", "DateRevised": {"Year": "2022", "Month": "01", "Day": "14"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "12", "Day": "22"}], "Language": ["eng"], "ELocationID": ["21", "10.3390/plants11010021"], "Journal": {"ISSN": "2223-7747", "JournalIssue": {"Volume": "11", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Dec", "Day": "22"}}, "Title": "Plants (Basel, Switzerland)", "ISOAbbreviation": "Plants (Basel)"}, "ArticleTitle": "Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System.", "Abstract": {"AbstractText": ["Essential oils (EOs) have been traditionally used as ancient remedies to treat many health disorders due to their enormous biological activities. As mainstream allopathic medication currently used for CNS disorders is associated with adverse effects, the search to obtain safer alternatives as compared to the currently marketed therapies is of tremendous significance. Research conducted suggests that concurrent utilization of allopathic medicines and EOs is synergistically beneficial. Due to their inability to show untoward effects, various scientists have tried to elucidate the pharmacological mechanisms by which these oils exert beneficial effects on the CNS. In this regard, our review aims to improve the understanding of EOs' biological activity on the CNS and to highlight the significance of the utilization of EOs in neuronal disorders, thereby improving patient acceptability of EOs as therapeutic agents. Through data compilation from library searches and electronic databases such as PubMed, Google Scholar, etc., recent preclinical and clinical data, routes of administration, and the required or maximal dosage for the observation of beneficial effects are addressed. We have also highlighted the challenges that require attention for further improving patient compliance, research gaps, and the development of EO-based nanomedicine for targeted therapy and pharmacotherapy."]}, "AuthorList": [{"Identifier": ["0000-0002-6738-2459"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal and Biological Chemistry, University of Toledo, 3000 Arlington Ave., Toledo, OH 43614, USA."}], "LastName": "Soares", "ForeName": "Giselle A Borges E", "Initials": "GABE"}, {"Identifier": ["0000-0003-4918-6849"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Innovation, Incubation & Industry (I-Cube) Laboratory, Techno India NJR Institute of Technology, Udaipur 313003, Rajasthan, India."}, {"Identifier": [], "Affiliation": "Department of Science & Engineering, Novel Global Community Educational Foundation, Hebersham, NSW 2770, Australia."}], "LastName": "Bhattacharya", "ForeName": "Tanima", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, Sir Padampat Singhania University, Udaipur 313601, Rajasthan, India."}], "LastName": "Chakrabarti", "ForeName": "Tulika", "Initials": "T"}, {"Identifier": ["0000-0002-0375-9165"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bhabha Pharmacy Research Institute, Bhabha University Bhopal, Bhopal 462026, Madhya Pradesh, India."}, {"Identifier": [], "Affiliation": "PRISAL Foundation (Pharmaceutical Royal International Society), Bhopal 462042, India."}], "LastName": "Tagde", "ForeName": "Priti", "Initials": "P"}, {"Identifier": ["0000-0001-7810-8925"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania."}], "LastName": "Cavalu", "ForeName": "Simona", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Plants (Basel)", "NlmUniqueID": "101596181", "ISSNLinking": "2223-7747"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ayaz M., Sadiq A., Junaid M., Ullah F., Subhan F., Ahmed J. Neuroprotective and Anti-Aging Potentials of Essential Oils from Aromatic and Medicinal Plants. Front. Aging Neurosci. 2017;9:168. doi: 10.3389/fnagi.2017.00168.", "ArticleIdList": ["10.3389/fnagi.2017.00168", "PMC5447774", "28611658"]}, {"Citation": "Lizarraga-Valderrama L.R. Effects of essential oils on central nervous system: Focus on mental health. Phytother. Res. 2021;35:657\u2013679. doi: 10.1002/ptr.6854.", "ArticleIdList": ["10.1002/ptr.6854", "32860651"]}, {"Citation": "ChStratakos A., Koidis A. Methods for Extracting Essential Oils. In: Preedy V.R., editor. Essential Oils in Food Preservation, Flavor and Safety. Academic Press; Cambridge, MA, USA: 2016. pp. 31\u201338."}, {"Citation": "Asl M.K., Nazariborun A., Hosseini M. Analgesic effect of the aqueous and ethanolic extracts of clove. Avicenna J. Phytomed. 2013;3:186\u2013192.", "ArticleIdList": ["PMC4075701", "25050273"]}, {"Citation": "Xu H., Delling M., Jun J.C., Clapham D.E. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 2006;9:628\u2013635. doi: 10.1038/nn1692.", "ArticleIdList": ["10.1038/nn1692", "16617338"]}, {"Citation": "Jirovetz L., Buchbauer G., Stoilova I., Stoyanova A., Krastanov A., Schmidt E. Chemical composition and antioxidant properties of clove leaf essential oil. J. Agric. Food Chem. 2006;54:6303\u20136307. doi: 10.1021/jf060608c.", "ArticleIdList": ["10.1021/jf060608c", "16910723"]}, {"Citation": "Mertens M., Buettner A., Kirchhoff E. The volatile constituents of frankincense\u2014A review. Flavour Fragr. J. 2009;24:279\u2013300. doi: 10.1002/ffj.1942.", "ArticleIdList": ["10.1002/ffj.1942"]}, {"Citation": "Okano S., Honda Y., Kodama T., Kimura M. The Effects of Frankincense Essential Oil on Stress in Rats. J. Oleo Sci. 2019;68:1003\u20131009. doi: 10.5650/jos.ess19114.", "ArticleIdList": ["10.5650/jos.ess19114", "31582666"]}, {"Citation": "Vuuren S.F.V., Kamatou G.P.P., Viljoen A.M. Volatile composition and antimicrobial activity of twenty commercial frankincense essential oil samples. South Afr. J. Bot. 2010;76:686\u2013691. doi: 10.1016/j.sajb.2010.06.001.", "ArticleIdList": ["10.1016/j.sajb.2010.06.001"]}, {"Citation": "Silva G.L., Luft C., Lunardelli A., Amaral R.H., Melo D.A., Donadio M.V., Nunes F.B., de Azambuja M.S., Santana J.C., Moraes C.M., et al. Antioxidant, analgesic and anti-inflammatory effects of lavender essential oil. An. Acad Bras. Cienc. 2015;87:1397\u20131408. doi: 10.1590/0001-3765201520150056.", "ArticleIdList": ["10.1590/0001-3765201520150056", "26247152"]}, {"Citation": "Scuteri D., Hamamura K., Sakurada T., Watanabe C., Sakurada S., Morrone L.A., Rombola L., Tonin P., Bagetta G., Corasaniti M.T. Efficacy of Essential Oils in Pain: A Systematic Review and Meta-Analysis of Preclinical Evidence. Front. Pharmacol. 2021;12:640128. doi: 10.3389/fphar.2021.640128.", "ArticleIdList": ["10.3389/fphar.2021.640128", "PMC7957371", "33732159"]}, {"Citation": "Lehrner J., Marwinski G., Lehr S., Johren P., Deecke L. Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol Behav. 2005;86:92\u201395. doi: 10.1016/j.physbeh.2005.06.031.", "ArticleIdList": ["10.1016/j.physbeh.2005.06.031", "16095639"]}, {"Citation": "Conrad P., Adams C. The effects of clinical aromatherapy for anxiety and depression in the high risk postpartum woman\u2014A pilot study. Complementary Ther. Clin. Pract. 2012;18:164\u2013168. doi: 10.1016/j.ctcp.2012.05.002.", "ArticleIdList": ["10.1016/j.ctcp.2012.05.002", "22789792"]}, {"Citation": "Okano K., Kaczmarzyk J.R., Dave N., Gabrieli J.D.E., Grossman J.C. Sleep quality, duration, and consistency are associated with better academic performance in college students. NPJ Sci. Learn. 2019;4:16. doi: 10.1038/s41539-019-0055-z.", "ArticleIdList": ["10.1038/s41539-019-0055-z", "PMC6773696", "31583118"]}, {"Citation": "Lillehei A.S., Halcon L.L., Savik K., Reis R. Effect of Inhaled Lavender and Sleep Hygiene on Self-Reported Sleep Issues: A Randomized Controlled Trial. J. Altern. Complementary Med. 2015;21:430\u2013438. doi: 10.1089/acm.2014.0327.", "ArticleIdList": ["10.1089/acm.2014.0327", "PMC4505755", "26133206"]}, {"Citation": "Faydali S., Cetinkaya F. The Effect of Aromatherapy on Sleep Quality of Elderly People Residing in a Nursing Home. Holist. Nurs. Pract. 2018;32:8\u201316. doi: 10.1097/HNP.0000000000000244.", "ArticleIdList": ["10.1097/HNP.0000000000000244", "29210873"]}, {"Citation": "Pokajewicz K., Bialon M., Svydenko L., Fedin R., Hudz N. Chemical Composition of the Essential Oil of the New Cultivars of Lavandula angustifolia Mill. Bred in Ukraine. Molecules. 2021;26:5681. doi: 10.3390/molecules26185681.", "ArticleIdList": ["10.3390/molecules26185681", "PMC8465323", "34577152"]}, {"Citation": "Malcolm B.J., Tallian K. Essential oil of lavender in anxiety disorders: Ready for prime time? Ment. Health Clin. 2017;7:147\u2013155. doi: 10.9740/mhc.2017.07.147.", "ArticleIdList": ["10.9740/mhc.2017.07.147", "PMC6007527", "29955514"]}, {"Citation": "Ekpenyong C.E., Akpan E.E. Use of Cymbopogon citratus essential oil in food preservation: Recent advances and future perspectives. Crit. Rev. Food Sci. Nutr. 2017;57:2541\u20132559. doi: 10.1080/10408398.2015.1016140.", "ArticleIdList": ["10.1080/10408398.2015.1016140", "26147358"]}, {"Citation": "Costa C.A., Cury T.C., Cassettari B.O., Takahira R.K., Florio J.C., Costa M. Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT(1A)-receptors and reduces cholesterol after repeated oral treatment. BMC Complementary Altern. Med. 2013;13:42. doi: 10.1186/1472-6882-13-42.", "ArticleIdList": ["10.1186/1472-6882-13-42", "PMC3598547", "23432968"]}, {"Citation": "Costa C.A., Kohn D.O., de Lima V.M., Gargano A.C., Florio J.C., Costa M. The GABAergic system contributes to the anxiolytic-like effect of essential oil from Cymbopogon citratus (lemongrass) J. Ethnopharmacol. 2011;137:828\u2013836. doi: 10.1016/j.jep.2011.07.003.", "ArticleIdList": ["10.1016/j.jep.2011.07.003", "21767622"]}, {"Citation": "Goes T.C., Ursulino F.R., Almeida-Souza T.H., Alves P.B., Teixeira-Silva F. Effect of Lemongrass Aroma on Experimental Anxiety in Humans. J. Altern. Complementary Med. 2015;21:766\u2013773. doi: 10.1089/acm.2015.0099.", "ArticleIdList": ["10.1089/acm.2015.0099", "26366471"]}, {"Citation": "Tan L.T., Lee L.H., Yin W.F., Chan C.K., Abdul Kadir H., Chan K.G., Goh B.H. Traditional Uses, Phytochemistry, and Bioactivities of Cananga odorata (Ylang-Ylang) Evid. Based Complementary Alternat. Med. 2015;2015:896314. doi: 10.1155/2015/896314.", "ArticleIdList": ["10.1155/2015/896314", "PMC4534619", "26294929"]}, {"Citation": "Zhang N., Zhang L., Feng L., Yao L. The anxiolytic effect of essential oil of Cananga odorata exposure on mice and determination of its major active constituents. Phytomedicine. 2016;23:1727\u20131734. doi: 10.1016/j.phymed.2016.10.017.", "ArticleIdList": ["10.1016/j.phymed.2016.10.017", "27912874"]}, {"Citation": "Jung D.J., Cha J.Y., Kim S.E., Ko I.G., Jee Y.S. Effects of Ylang-Ylang aroma on blood pressure and heart rate in healthy men. J. Exerc. Rehabil. 2013;9:250\u2013255. doi: 10.12965/jer.130007.", "ArticleIdList": ["10.12965/jer.130007", "PMC3836517", "24278868"]}, {"Citation": "Zhang N., Zhang L., Feng L., Yao L. Cananga odorata essential oil reverses the anxiety induced by 1-(3-chlorophenyl) piperazine through regulating the MAPK pathway and serotonin system in mice. J. Ethnopharmacol. 2018;219:23\u201330. doi: 10.1016/j.jep.2018.03.013.", "ArticleIdList": ["10.1016/j.jep.2018.03.013", "29545208"]}, {"Citation": "Giang P.M., Son P.T. GC and GC-MS analysis of the fresh flower essential oil of Cananga odorata (Lam) Hook. f. et Th. var. fruticosa (Craib) J. Sincl. Am. J. Essent. Oils Nat. Prod. 2016;4:9\u201311."}, {"Citation": "Hwang E.S., Kim H.B., Lee S., Kim M.J., Kim K.J., Han G., Han S.Y., Lee E.A., Yoon J.H., Kim D.O., et al. Antidepressant-like effects of beta-caryophyllene on restraint plus stress-induced depression. Behav. Brain Res. 2020;380:112439. doi: 10.1016/j.bbr.2019.112439.", "ArticleIdList": ["10.1016/j.bbr.2019.112439", "31862467"]}, {"Citation": "Sohrabi R., Pazgoohan N., Seresht H.R., Amin B. Repeated systemic administration of the cinnamon essential oil possesses anti-anxiety and anti-depressant activities in mice. Iran. J. Basic. Med. Sci. 2017;20:708\u2013714. doi: 10.22038/IJBMS.2017.8841.", "ArticleIdList": ["10.22038/IJBMS.2017.8841", "PMC5569441", "28868126"]}, {"Citation": "Chen Y.F., Wang Y.W., Huang W.S., Lee M.M., Wood W.G., Leung Y.M., Tsai H.Y. Trans-Cinnamaldehyde, An Essential Oil in Cinnamon Powder, Ameliorates Cerebral Ischemia-Induced Brain Injury via Inhibition of Neuroinflammation Through Attenuation of iNOS, COX-2 Expression and NFkappa-B Signaling Pathway. Neuromolecular. Med. 2016;18:322\u2013333. doi: 10.1007/s12017-016-8395-9.", "ArticleIdList": ["10.1007/s12017-016-8395-9", "27087648"]}, {"Citation": "Iwasaki Y., Tanabe M., Kobata K., Watanabe T. TRPA1 agonists--allyl isothiocyanate and cinnamaldehyde--induce adrenaline secretion. Biosci. Biotechnol. Biochem. 2008;72:2608\u20132614. doi: 10.1271/bbb.80289.", "ArticleIdList": ["10.1271/bbb.80289", "18838811"]}, {"Citation": "Alizadeh Behbahani B., Falah F., Lavi Arab F., Vasiee M., Tabatabaee Yazdi F. Chemical Composition and Antioxidant, Antimicrobial, and Antiproliferative Activities of Cinnamomum zeylanicum Bark Essential Oil. Evid. Based. Complementary Altern. Med. 2020;2020:5190603. doi: 10.1155/2020/5190603.", "ArticleIdList": ["10.1155/2020/5190603", "PMC7210559", "32419807"]}, {"Citation": "Sebei K., Sakouhi F., Herchi W., Khouja M.L., Boukhchina S. Chemical composition and antibacterial activities of seven Eucalyptus species essential oils leaves. Biol. Res. 2015;48:7. doi: 10.1186/0717-6287-48-7.", "ArticleIdList": ["10.1186/0717-6287-48-7", "PMC4417289", "25654423"]}, {"Citation": "Juergens U.R. Anti-inflammatory properties of the monoterpene 1.8-cineole: Current evidence for co-medication in inflammatory airway diseases. Drug Res. 2014;64:638\u2013646. doi: 10.1055/s-0034-1372609.", "ArticleIdList": ["10.1055/s-0034-1372609", "24831245"]}, {"Citation": "Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Nissen L., Zatta A., Stefanini I., Grandi S., Sgorbati B., Biavati B., Monti A. Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.) Fitoterapia. 2010;81:413\u2013419. doi: 10.1016/j.fitote.2009.11.010.", "ArticleIdList": ["10.1016/j.fitote.2009.11.010", "19969046"]}, {"Citation": "Brett A.E., A.Webster A. Chapter 132\u2014Acetylcholinesterase and its Inhibitors. In: Robertson D., Burnstock G., Paton J.F.R., Biaggioni I., Low P.A., editors. Primer on the Autonomic Nervous System (Third Edition) 3rd ed. Academic Press; Cambridge, MA, USA: 2012."}, {"Citation": "Jun Y.S., Kang P., Min S.S., Lee J.M., Kim H.K., Seol G.H. Effect of eucalyptus oil inhalation on pain and inflammatory responses after total knee replacement: A randomized clinical trial. Evid. Based Complementary Altern. Med. 2013;2013:502727. doi: 10.1155/2013/502727.", "ArticleIdList": ["10.1155/2013/502727", "PMC3703330", "23853660"]}, {"Citation": "Hsouna A.B., Touj N., Hammami I., Dridi K., Al-Ayed A.S., Hamdi N. Chemical Composition and in vivo Efficacy of the Essential Oil of Mentha piperita L. in the Suppression of Crown Gall Disease on Tomato Plants. J. Oleo Sci. 2019;68:419\u2013426. doi: 10.5650/jos.ess18261.", "ArticleIdList": ["10.5650/jos.ess18261", "30867394"]}, {"Citation": "Masomeh L., Narges M., Hassan R.A.H. Peppermint and Its Functionality: A Review. Arch. Clin. Microbiol. 2017;7:4. doi: 10.4172/1989-8436.100054.", "ArticleIdList": ["10.4172/1989-8436.100054"]}, {"Citation": "Umezu T. Evaluation of the effects of plant-derived essential oils on central nervous system function using discrete shuttle-type conditioned avoidance response in mice. Phytother. Res. 2012;26:884\u2013891. doi: 10.1002/ptr.3665.", "ArticleIdList": ["10.1002/ptr.3665", "22086772"]}, {"Citation": "Kennedy D., Okello E., Chazot P., Howes M.J., Ohiomokhare S., Jackson P., Haskell-Ramsay C., Khan J., Forster J., Wightman E. Volatile Terpenes and Brain Function: Investigation of the Cognitive and Mood Effects of Mentha \u00d7 Piperita L. Essential Oil with In Vitro Properties Relevant to Central Nervous System Function. Nutrients. 2018;10:1029. doi: 10.3390/nu10081029.", "ArticleIdList": ["10.3390/nu10081029", "PMC6116079", "30087294"]}, {"Citation": "Bhadania M., Joshi H., Patel P., Kulkarni V.H. Protective effect of menthol on beta-amyloid peptide induced cognitive deficits in mice. Eur. J. Pharmacol. 2012;681:50\u201354. doi: 10.1016/j.ejphar.2012.01.035.", "ArticleIdList": ["10.1016/j.ejphar.2012.01.035", "22329901"]}, {"Citation": "Schmidt E., Bail S., Buchbauer G., Stoilova I., Atanasova T., Stoyanova A., Krastanov A., Jirovetz L. Chemical composition, olfactory evaluation and antioxidant effects of essential oil from Mentha \u00d7 piperita. Nat. Prod. Commun. 2009;4:1107\u20131112. doi: 10.1177/1934578X0900400819.", "ArticleIdList": ["10.1177/1934578X0900400819", "19768994"]}, {"Citation": "Moss M., Hewitt S., Moss L., Wesnes K. Modulation of cognitive performance and mood by aromas of peppermint and ylang-ylang. Int. J. Neurosci. 2008;118:59\u201377. doi: 10.1080/00207450601042094.", "ArticleIdList": ["10.1080/00207450601042094", "18041606"]}, {"Citation": "Elyemni M., Louaste B., Nechad I., Elkamli T., Bouia A., Taleb M., Chaouch M., Eloutassi N. Extraction of Essential Oils of Rosmarinus officinalis L. by Two Different Methods: Hydrodistillation and Microwave Assisted Hydrodistillation. Sci. World J. 2019;2019:3659432. doi: 10.1155/2019/3659432.", "ArticleIdList": ["10.1155/2019/3659432", "PMC6463580", "31057339"]}, {"Citation": "Villareal M.O., Ikeya A., Sasaki K., Arfa A.B., Neffati M., Isoda H. Anti-stress and neuronal cell differentiation induction effects of Rosmarinus officinalis L. essential oil. BMC Complementary Altern. Med. 2017;17:549. doi: 10.1186/s12906-017-2060-1.", "ArticleIdList": ["10.1186/s12906-017-2060-1", "PMC5741888", "29273038"]}, {"Citation": "Habtemariam S. The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer\u2019s Disease. Evid. Based Complementary Altern. Med. 2016;2016:2680409. doi: 10.1155/2016/2680409.", "ArticleIdList": ["10.1155/2016/2680409", "PMC4749867", "26941822"]}, {"Citation": "Ozcan M.M., Chalchat J.C. Chemical composition and antifungal activity of rosemary (Rosmarinus officinalis L.) oil from Turkey. Int. J. Food Sci. Nutr. 2008;59:691\u2013698. doi: 10.1080/09637480701777944.", "ArticleIdList": ["10.1080/09637480701777944", "18654909"]}, {"Citation": "Jiang Y., Wu N., Fu Y.J., Wang W., Luo M., Zhao C.J., Zu Y.G., Liu X.L. Chemical composition and antimicrobial activity of the essential oil of Rosemary. Environ. Toxicol. Pharmacol. 2011;32:63\u201368. doi: 10.1016/j.etap.2011.03.011.", "ArticleIdList": ["10.1016/j.etap.2011.03.011", "21787731"]}, {"Citation": "Khedher M.R.B., Khedher S.B., Chaieb I., Tounsi S., Hammami M. Chemical composition and biological activities of Salvia officinalis essential oil from Tunisia. EXCLI J. 2017;16:160\u2013173. doi: 10.17179/excli2016-832.", "ArticleIdList": ["10.17179/excli2016-832", "PMC5427463", "28507464"]}, {"Citation": "Moss M., Rouse M., Moss L. Aromas of Salvia Species Enhance Everyday Prospective Memory Performance in Healthy Young Adults. Adv. Chem. Eng. Sci. 2014;4:339\u2013346. doi: 10.4236/aces.2014.43037.", "ArticleIdList": ["10.4236/aces.2014.43037"]}, {"Citation": "Lopresti A.L. Salvia (Sage): A Review of its Potential Cognitive-Enhancing and Protective Effects. Drugs R D. 2017;17:53\u201364. doi: 10.1007/s40268-016-0157-5.", "ArticleIdList": ["10.1007/s40268-016-0157-5", "PMC5318325", "27888449"]}, {"Citation": "Akhondzadeh S., Noroozian M., Mohammadi M., Ohadinia S., Jamshidi A.H., Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: A double blind, randomized and placebo-controlled trial. J. Clin. Pharm. Ther. 2003;28:53\u201359. doi: 10.1046/j.1365-2710.2003.00463.x.", "ArticleIdList": ["10.1046/j.1365-2710.2003.00463.x", "12605619"]}, {"Citation": "Craft J.D., Satyal P., Setzer W.N. The Chemotaxonomy of Common Sage (Salvia officinalis) Based on the Volatile Constituents. Medicines. 2017;4:47. doi: 10.3390/medicines4030047.", "ArticleIdList": ["10.3390/medicines4030047", "PMC5622382", "28930262"]}, {"Citation": "Braun N.A., Sim S., Kohlenberg B., Lawrence B.M. Hawaiian sandalwood: Oil composition of Santalum paniculatum and comparison with other sandal species. Nat. Prod. Commun. 2014;9:1365\u20131368. doi: 10.1177/1934578X1400900936.", "ArticleIdList": ["10.1177/1934578X1400900936", "25918813"]}, {"Citation": "Safwat Y.N., Elsayed M.M. Sandalwood oil neuroprotective effects on middle cerebral artery occlusion model of ischemic brain stroke. Farmacogn. Mag. 2020;16:117\u2013122."}, {"Citation": "Misra B.B., Dey S. Biological Activities of East Indian Sandalwood Tree, Santalum album. PeerJ. 2013;1:e96v1.", "ArticleIdList": ["0"]}, {"Citation": ". Misra B.B., Dey S. Evaluation of in vivo anti-hyperglycemic and antioxidant potentials of alpha-santalol and sandalwood oil. Phytomedicine. 2013;20:409\u2013416. doi: 10.1016/j.phymed.2012.12.017.", "ArticleIdList": ["10.1016/j.phymed.2012.12.017", "23369343"]}, {"Citation": "Hoferl M., Hutter C., Buchbauer G. A Pilot Study on the Physiological Effects of Three Essential Oils in Humans. Nat. Prod. Commun. 2016;11:1561\u20131564. doi: 10.1177/1934578X1601101034.", "ArticleIdList": ["10.1177/1934578X1601101034", "30549622"]}, {"Citation": "Kusuma H.S., Mahfud M. Chemical composition of essential oil of Indonesia sandalwood extracted by microwave-assisted hydrodistillation. AIP Conf. Proc. 2016;1755:050001."}, {"Citation": "Moss M., Cook J., Wesnes K., Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int. J. Neurosci. 2003;113:15\u201338. doi: 10.1080/00207450390161903.", "ArticleIdList": ["10.1080/00207450390161903", "12690999"]}, {"Citation": "Hadi N., Hanid A.A. Lavender Essence for Post-cesarean pain. Pak. J. Biol. Sci. 2011;14:664\u2013667. doi: 10.3923/pjbs.2011.664.667.", "ArticleIdList": ["10.3923/pjbs.2011.664.667", "22235509"]}, {"Citation": "Sayorwan W., Ruangrungsi N., Piriyapunyporn T., Hongratanaworakit T., Kotchabhakdi N., Siripornpanich V. Effects of inhaled rosemary oil on subjective feelings and activities of the nervous system. Sci. Pharm. 2013;81:531\u2013542. doi: 10.3797/scipharm.1209-05.", "ArticleIdList": ["10.3797/scipharm.1209-05", "PMC3700080", "23833718"]}, {"Citation": "Moss L., Rouse M., Wesnes K.A., Moss M. Differential effects of the aromas of Salvia species on memory and mood. Hum. Psychopharmacol. 2010;25:388\u2013396. doi: 10.1002/hup.1129.", "ArticleIdList": ["10.1002/hup.1129", "20589925"]}, {"Citation": "Boehm K., Bussing A., Ostermann T. Aromatherapy as an adjuvant treatment in cancer care--a descriptive systematic review. Afr. J. Tradit. Complementary Altern. Med. 2012;9:503\u2013518. doi: 10.4314/ajtcam.v9i4.7.", "ArticleIdList": ["10.4314/ajtcam.v9i4.7", "PMC3746639", "23983386"]}, {"Citation": "Lakhan S.E., Sheafer H., Tepper D. The Effectiveness of Aromatherapy in Reducing Pain: A Systematic Review and Meta-Analysis. Pain Res. Treat. 2016;2016:8158693. doi: 10.1155/2016/8158693.", "ArticleIdList": ["10.1155/2016/8158693", "PMC5192342", "28070420"]}, {"Citation": "Yang S., Chang M.C. Chronic Pain: Structural and Functional Changes in Brain Structures and Associated Negative Affective States. Int. J. Mol. Sci. 2019;20:3130. doi: 10.3390/ijms20133130.", "ArticleIdList": ["10.3390/ijms20133130", "PMC6650904", "31248061"]}, {"Citation": "Wang Z.J., Heinbockel T. Essential Oils and Their Constituents Targeting the GABAergic System and Sodium Channels as Treatment of Neurological Diseases. Molecules. 2018;23:1061. doi: 10.3390/molecules23051061.", "ArticleIdList": ["10.3390/molecules23051061", "PMC6099651", "29724056"]}, {"Citation": "WHO  Depression.  [(accessed on 1 May 2021)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/depression."}, {"Citation": "Thibaut F. Anxiety disorders: A review of current literature. Dialogues Clin. Neurosci. 2017;19:87\u201388.", "ArticleIdList": ["PMC5573565", "28867933"]}, {"Citation": "Ogata K., Ataka K., Suzuki H., Yagi T., Okawa A., Fukumoto T., Zhang B., Nakata M., Yada T., Asakawa A. Lavender Oil Reduces Depressive Mood in Healthy Individuals and Enhances the Activity of Single Oxytocin Neurons of the Hypothalamus Isolated from Mice: A Preliminary Study. Evid. Based Complementary Altern. Med. 2020;2020:5418586. doi: 10.1155/2020/5418586.", "ArticleIdList": ["10.1155/2020/5418586", "PMC7376415", "32733584"]}, {"Citation": "WHO  Dementia.  [(accessed on 1 May 2021)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/dementia."}, {"Citation": "National Institute of Ageing  Treatment of Alzeimers Disease.  [(accessed on 1 May 2021)]; Available online:  https://www.nia.nih.gov/health/how-alzheimers-disease-treated."}, {"Citation": "Santarsieri D., Schwartz T.L. Antidepressant efficacy and side-effect burden: A quick guide for clinicians. Drugs Context. 2015;4:212290. doi: 10.7573/dic.212290.", "ArticleIdList": ["10.7573/dic.212290", "PMC4630974", "26576188"]}, {"Citation": "Filiptsova O.V., Gazzavi-Rogozina L.V., Timoshyna I.A., Naboka O.I., Dyomina Y.V., Ochkur A.V. The effect of the essential oils of lavender and rosemary on the human short-term memory. Alex. J. Med. 2018;54:41\u201344. doi: 10.1016/j.ajme.2017.05.004.", "ArticleIdList": ["10.1016/j.ajme.2017.05.004"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Moher D. Updating guidance for reporting systematic reviews: Development of the PRISMA 2020 statement. J. Clin. Epidemiol. 2021;134:103\u2013112. doi: 10.1016/j.jclinepi.2021.02.003.", "ArticleIdList": ["10.1016/j.jclinepi.2021.02.003", "33577987"]}, {"Citation": "Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M., Akl E.A., Brennan S.E., et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J. Clin. Epidemiol. 2021;134:178\u2013189. doi: 10.1016/j.jclinepi.2021.03.001.", "ArticleIdList": ["10.1016/j.jclinepi.2021.03.001", "33789819"]}, {"Citation": "Dagli N., Dagli R., Mahmoud R.S., Baroudi K. Essential oils, their therapeutic properties, and implication in dentistry: A review. J. Int. Soc. Prev. Community Dent. 2015;5:335\u2013340. doi: 10.4103/2231-0762.165933.", "ArticleIdList": ["10.4103/2231-0762.165933", "PMC4606594", "26539382"]}, {"Citation": "S\u00e1 R.D.C.D.S.E., Lima T.C., da N\u00f3brega F.R., Brito A.E.M.D., de Sousa D.P. Analgesic-Like Activity of Essential Oil Constituents: An Update. Int. J. Mol. Sci. 2017;12:2932. doi: 10.3390/ijms18122392.", "ArticleIdList": ["10.3390/ijms18122392", "PMC5751100", "29232831"]}, {"Citation": "Pramod K., Ansari S.H., Ali J. Eugenol: A Natural Compound with Versatile Pharmacological Actions. Nat. Prod. Commun. 2010;5:1999\u20132006. doi: 10.1177/1934578X1000501236.", "ArticleIdList": ["10.1177/1934578X1000501236", "21299140"]}, {"Citation": "Chung G., Rhee J.N., Jung S.J., Kim J.S., Oh S.B. Modulation of CaV2.3 calcium channel currents by eugenol. J. Dent. Res. 2008;87:137\u2013141. doi: 10.1177/154405910808700201.", "ArticleIdList": ["10.1177/154405910808700201", "18218839"]}, {"Citation": "Cho J.S., Kim T.H., Lim J.M., Song J.H. Effects of eugenol on Na+ currents in rat dorsal root ganglion neurons. Brain Res. 2008;1243:53\u201362. doi: 10.1016/j.brainres.2008.09.030.", "ArticleIdList": ["10.1016/j.brainres.2008.09.030", "18824159"]}, {"Citation": "Aoshima H., Hamamoto K. Potentiation of GABAA Receptors Expressed in Xenopus Oocytes by Perfume and Phytoncid. Biosci. Biotechnol. Biochem. 1999;63:743\u2013748. doi: 10.1271/bbb.63.743.", "ArticleIdList": ["10.1271/bbb.63.743", "10361687"]}, {"Citation": "Dal Bo W., Luiz A.P., Martins D.F., Mazzardo-Martins L., Santos A.R. Eugenol reduces acute pain in mice by modulating the glutamatergic and tumor necrosis factor alpha (TNF-alpha) pathways. Fundam. Clin. Pharmacol. 2013;27:517\u2013525. doi: 10.1111/j.1472-8206.2012.01052.x.", "ArticleIdList": ["10.1111/j.1472-8206.2012.01052.x", "22775297"]}, {"Citation": "Dhiman P., Malik N., Khatkar A. Lead optimization for promising monoamine oxidase inhibitor from eugenol for the treatment of neurological disorder: Synthesis and in silico based study. BMC Chem. 2019;13:38. doi: 10.1186/s13065-019-0552-4.", "ArticleIdList": ["10.1186/s13065-019-0552-4", "PMC6661809", "31384786"]}, {"Citation": "Holanda Pinto S.A., Pinto L.M., Guedes M.A., Cunha G.M., Chaves M.H., Santos F.A., Rao V.S. Antinoceptive effect of triterpenoid alpha,beta-amyrin in rats on orofacial pain induced by formalin and capsaicin. Phytomedicine. 2008;15:630\u2013634. doi: 10.1016/j.phymed.2007.11.016.", "ArticleIdList": ["10.1016/j.phymed.2007.11.016", "18164607"]}, {"Citation": "Ven\u00e2ncio A.M., Marchioro M., Estavam C.S., Melo M.S., Santana M.T., Onofre A.S.C., Guimar\u00e3es A.G., Oliveira M.G.B., Alves P.B., Pimentel H.D.C., et al. Ocimum basilicum leaf essential oil and (-)-linalool reduce orofacial nociception in rodents: A behavioral and electrophysiological approach. Braz. J. Farmacogn. 2011;21:1043\u20131051. doi: 10.1590/S0102-695X2011005000147.", "ArticleIdList": ["10.1590/S0102-695X2011005000147"]}, {"Citation": "Andersen P., Bliss T.V., Skrede K.K. Unit analysis of hippocampal polulation spikes. Exp. Brain Res. 1971;13:208\u2013221. doi: 10.1007/BF00234086.", "ArticleIdList": ["10.1007/BF00234086", "5123965"]}, {"Citation": "Peana A.T., De Montis M.G., Nieddu E., Spano M.T., D\u2019Aquila P.S., Pippia P. Profile of spinal and supra-spinal antinociception of (-)-linalool. Eur. J. Pharmacol. 2004;485:165\u2013174. doi: 10.1016/j.ejphar.2003.11.066.", "ArticleIdList": ["10.1016/j.ejphar.2003.11.066", "14757137"]}, {"Citation": "Peana A.T., D\u2019Aquila P.S., Chessa M.L., Moretti M.D., Serra G., Pippia P. (-)-Linalool produces antinociception in two experimental models of pain. Eur. J. Pharmacol. 2003;460:37\u201341. doi: 10.1016/S0014-2999(02)02856-X.", "ArticleIdList": ["10.1016/S0014-2999(02)02856-X", "12535857"]}, {"Citation": "Tashiro S., Yamaguchi R., Ishikawa S., Sakurai T., Kajiya K., Kanmura Y., Kuwaki T., Kashiwadani H. Odour-induced analgesia mediated by hypothalamic orexin neurons in mice. Sci. Rep. 2016;6:37129. doi: 10.1038/srep37129.", "ArticleIdList": ["10.1038/srep37129", "PMC5109046", "27845440"]}, {"Citation": "Johnson S.A., Rodriguez D., Allred K. A Systematic Review of Essential Oils and the Endocannabinoid System: A Connection Worthy of Further Exploration. Evid. Based Complementary Altern. Med. 2020;2020:8035301. doi: 10.1155/2020/8035301.", "ArticleIdList": ["10.1155/2020/8035301", "PMC7246407", "32508955"]}, {"Citation": "Anxiety and Depression Association of America  Anxiety, Facts and Statistics.  [(accessed on 1 May 2021)].  Available online:  https://adaa.org/understanding-anxiety/facts-statistics."}, {"Citation": "MayoClinic  Anxiety Disorders, Diagnosis and Treatment.  [(accessed on 1 May 2021)].  Available online:  https://www.mayoclinic.org/diseases-conditions/anxiety/diagnosis-treatment/drc-20350967."}, {"Citation": "NIH  Depression.  [(accessed on 1 May 2021)]; Available online:  https://www.nimh.nih.gov/health/topics/depression/"}, {"Citation": "MayoClinic  Depression (Major Depressive Disorder)  [(accessed on 1 May 2021)].  Available online:  https://www.mayoclinic.org/diseases-conditions/depression/symptoms-causes/syc-20356007."}, {"Citation": "Machado K.D.C., Islam M.T., Ali E.S., Rouf R., Uddin S.J., Dev S., Shilpi J.A., Shill M.C., Reza H.M., Das A.K., et al. A systematic review on the neuroprotective perspectives of beta-caryophyllene. Phytother. Res. 2018;32:2376\u20132388. doi: 10.1002/ptr.6199.", "ArticleIdList": ["10.1002/ptr.6199", "30281175"]}, {"Citation": "Galaj E., Xi Z.X. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders. CNS Drugs. 2019;33:1001\u20131030. doi: 10.1007/s40263-019-00664-w.", "ArticleIdList": ["10.1007/s40263-019-00664-w", "PMC7451396", "31549358"]}, {"Citation": "Johnson W.G. Late-onset neurodegenerative diseases--the role of protein insolubility. Pt 4J. Anat. 2000;196:609\u2013616. doi: 10.1046/j.1469-7580.2000.19640609.x.", "ArticleIdList": ["10.1046/j.1469-7580.2000.19640609.x", "PMC1468101", "10923991"]}, {"Citation": "Gertsch J. Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action? Commun. Integr. Biol. 2008;1:26\u201328. doi: 10.4161/cib.1.1.6568.", "ArticleIdList": ["10.4161/cib.1.1.6568", "PMC2633791", "19704783"]}, {"Citation": "Paula-Freire L.I., Andersen M.L., Gama V.S., Molska G.R., Carlini E.L. The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice. Phytomedicine. 2014;21:356\u2013362. doi: 10.1016/j.phymed.2013.08.006.", "ArticleIdList": ["10.1016/j.phymed.2013.08.006", "24055516"]}, {"Citation": "Katsuyama S., Mizoguchi H., Kuwahata H., Komatsu T., Nagaoka K., Nakamura H., Bagetta G., Sakurada T., Sakurada S. Involvement of peripheral cannabinoid and opioid receptors in beta-caryophyllene-induced antinociception. Eur. J. Pain. 2013;17:664\u2013675. doi: 10.1002/j.1532-2149.2012.00242.x.", "ArticleIdList": ["10.1002/j.1532-2149.2012.00242.x", "23138934"]}, {"Citation": "Association A.S. What Is Alzheimer\u2019s Disease?  [(accessed on 1 May 2021)].  Available online:  https://www.alz.org/alzheimers-dementia/what-is-alzheimers."}, {"Citation": "National Institute on Ageing  Alzheimer\u2019s Disease Fact Sheet.  [(accessed on 1 May 2021)]; Available online:  https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet."}, {"Citation": "Reiman E.M., Langbaum J.B., Fleisher A.S., Caselli R.J., Chen K., Ayutyanont N., Quiroz Y.T., Kosik K.S., Lopera F., Tariot P.N. Alzheimer\u2019s Prevention Initiative: A plan to accelerate the evaluation of presymptomatic treatments. J. Alzheimers Dis. 2011;26((Suppl. 3)):321\u2013329. doi: 10.3233/JAD-2011-0059.", "ArticleIdList": ["10.3233/JAD-2011-0059", "PMC3343739", "21971471"]}, {"Citation": "Lawther B.K., Kumar S., Krovvidi H. Continuing Education in Anaesthesia, Critical Care and Pain. Volume 11 Oxford Academic; Oxford, UK: 2011. Blood\u2013brain barrier."}, {"Citation": "Wong H.L., Bendayan R., Rauth A.M., Li Y., Wu X.Y. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv. Drug Deliv. Rev. 2007;59:491\u2013504. doi: 10.1016/j.addr.2007.04.008.", "ArticleIdList": ["10.1016/j.addr.2007.04.008", "17532091"]}, {"Citation": "Palmerston Mendes L., Pan J., Torchilin V.P. Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy. Molecules. 2017;22:1401. doi: 10.3390/molecules22091401.", "ArticleIdList": ["10.3390/molecules22091401", "PMC5600151", "28832535"]}, {"Citation": "Smith D.K. Designing Dendrimers. Wiley; Hoboken, NJ, USA: 2012."}, {"Citation": "Xu L., Zhang H., Wu Y. Dendrimer advances for the central nervous system delivery of therapeutics. ACS Chem. Neurosci. 2014;5:2\u201313. doi: 10.1021/cn400182z.", "ArticleIdList": ["10.1021/cn400182z", "PMC3894720", "24274162"]}, {"Citation": "Menjoge A.R., Kannan R.M., Tomalia D.A. Dendrimer-based drug and imaging conjugates: Design considerations for nanomedical applications. Drug Discov. Today. 2010;15:171\u2013185. doi: 10.1016/j.drudis.2010.01.009.", "ArticleIdList": ["10.1016/j.drudis.2010.01.009", "20116448"]}, {"Citation": "Huang R.Q., Qu Y.H., Ke W.L., Zhu J.H., Pei Y.Y., Jiang C. Efficient gene delivery targeted to the brain using a transferrin-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. FASEB J. 2007;21:1117\u20131125. doi: 10.1096/fj.06-7380com.", "ArticleIdList": ["10.1096/fj.06-7380com", "17218540"]}, {"Citation": "Huang R., Ke W., Han L., Li J., Liu S., Jiang C. Targeted delivery of chlorotoxin-modified DNA-loaded nanoparticles to glioma via intravenous administration. Biomaterials. 2011;32:2399\u20132406. doi: 10.1016/j.biomaterials.2010.11.079.", "ArticleIdList": ["10.1016/j.biomaterials.2010.11.079", "21185076"]}, {"Citation": "He H., Li Y., Jia X.R., Du J., Ying X., Lu W.L., Lou J.N., Wei Y. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors. Biomaterials. 2011;32:478\u2013487. doi: 10.1016/j.biomaterials.2010.09.002.", "ArticleIdList": ["10.1016/j.biomaterials.2010.09.002", "20934215"]}, {"Citation": "Liu Y., Huang R., Han L., Ke W., Shao K., Ye L., Lou J., Jiang C. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles. Biomaterials. 2009;30:4195\u20134202. doi: 10.1016/j.biomaterials.2009.02.051.", "ArticleIdList": ["10.1016/j.biomaterials.2009.02.051", "19467700"]}, {"Citation": "Tagde P., Tagde P., Tagde S., Bhattacharya T., Garg V., Akter R., Rahman M.H., Najda A., Albadrani G.M., Sayed A.A., et al. Natural bioactive molecules: An alternative approach to the treatment and control of glioblastoma multiforme. Biomed. Pharmacother. 2021;141:111928. doi: 10.1016/j.biopha.2021.111928.", "ArticleIdList": ["10.1016/j.biopha.2021.111928", "34323701"]}, {"Citation": "Sharma A., Sharma R., Zhang Z., Liaw K., Kambhampati S.P., Porterfield J.E., Lin K.C., DeRidder L.B., Kannan S., Kannan R.M. Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders. Sci. Adv. 2020;6:eaay8514. doi: 10.1126/sciadv.aay8514.", "ArticleIdList": ["10.1126/sciadv.aay8514", "PMC6976300", "32010790"]}, {"Citation": "Sultana F., Manirujjaman, Imran-Ul-Haque M., Arafat M., Sharmin S. An Overview of Nanogel Drug Delivery System. J. Appl. Pharm. Sci. 2013;3:95\u2013105."}, {"Citation": "Kabanov A.V., Gendelman H.E. Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog. Polym. Sci. 2007;32:1054\u20131082. doi: 10.1016/j.progpolymsci.2007.05.014.", "ArticleIdList": ["10.1016/j.progpolymsci.2007.05.014", "PMC2838200", "20234846"]}, {"Citation": "Vinogradov S. The second annual symposium on nanomedicine and drug delivery: Exploring recent developments and assessing major advances. 19-20 August 2004, Polytechnic University, Brooklyn, NY, USA. Expert. Opin. Drug Deliv. 2004;1:181\u2013184. doi: 10.1517/17425247.1.1.181.", "ArticleIdList": ["10.1517/17425247.1.1.181", "PMC1351158", "16296729"]}, {"Citation": "Vinogradov S.V., Batrakova E.V., Kabanov A.V. Nanogels for oligonucleotide delivery to the brain. Bioconjug. Chem. 2004;15:50\u201360. doi: 10.1021/bc034164r.", "ArticleIdList": ["10.1021/bc034164r", "PMC2837941", "14733583"]}, {"Citation": "Azadi A., Rouini M.R., Hamidi M. Neuropharmacokinetic evaluation of methotrexate-loaded chitosan nanogels. Int. J. Biol. Macromol. 2015;79:326\u2013335. doi: 10.1016/j.ijbiomac.2015.05.001.", "ArticleIdList": ["10.1016/j.ijbiomac.2015.05.001", "25959975"]}, {"Citation": "Gulyaev A.E., Gelperina S.E., Skidan I.N., Antropov A.S., Kivman G.Y., Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles. Pharm. Res. 1999;16:1564\u20131569. doi: 10.1023/A:1018983904537.", "ArticleIdList": ["10.1023/A:1018983904537", "10554098"]}, {"Citation": "Kumar A., Chaudhary R.K., Singh R., Singh S.P., Wang S.Y., Hoe Z.Y., Pan C.T., Shiue Y.L., Wei D.Q., Kaushik A.C., et al. Nanotheranostic Applications for Detection and Targeting Neurodegenerative Diseases. Front. Neurosci. 2020;14:305. doi: 10.3389/fnins.2020.00305.", "ArticleIdList": ["10.3389/fnins.2020.00305", "PMC7203731", "32425743"]}, {"Citation": "Goyal K., Koul V., Singh Y., Anand A. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: Trends and advances. Cent. Nerv. Syst. Agents Med. Chem. 2014;14:43\u201359. doi: 10.2174/1871524914666141030145948.", "ArticleIdList": ["10.2174/1871524914666141030145948", "25360772"]}, {"Citation": "Saeedi M., Eslamifar M., Khezri K., Dizaj S.M. Applications of nanotechnology in drug delivery to the central nervous system. Biomed. Pharmacother. 2019;111:666\u2013675. doi: 10.1016/j.biopha.2018.12.133.", "ArticleIdList": ["10.1016/j.biopha.2018.12.133", "30611991"]}, {"Citation": "Kafa H., Wang J.T., Rubio N., Venner K., Anderson G., Pach E., Ballesteros B., Preston J.E., Abbott N.J., Al-Jamal K.T. The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo. Biomaterials. 2015;53:437\u2013452. doi: 10.1016/j.biomaterials.2015.02.083.", "ArticleIdList": ["10.1016/j.biomaterials.2015.02.083", "PMC4407899", "25890741"]}, {"Citation": "Aziz Z.A.A., Nasir H.M., Ahmad A., Setapar S.H.M., Ahmad H., Noor M.H.M., Rafatullah M., Khatoon A., Kausar M.A., Ahmad I., et al. Enrichment of Eucalyptus oil nanoemulsion by micellar nanotechnology: Transdermal analgesic activity using hot plate test in rats\u2019 assay. Sci. Rep. 2019;9:13678. doi: 10.1038/s41598-019-50134-y.", "ArticleIdList": ["10.1038/s41598-019-50134-y", "PMC6757054", "31548590"]}, {"Citation": "Scuteri D., Cassano R., Trombino S., Russo R., Mizoguchi H., Watanabe C., Hamamura K., Katsuyama S., Komatsu T., Morrone L.A., et al. Development and Translation of NanoBEO, a Nanotechnology-Based Delivery System of Bergamot Essential Oil Deprived of Furocumarins, in the Control of Agitation in Severe Dementia. Pharmaceutics. 2021;13:379. doi: 10.3390/pharmaceutics13030379.", "ArticleIdList": ["10.3390/pharmaceutics13030379", "PMC7999378", "33809385"]}, {"Citation": "Gaude T.T., Soares G.A.B.E., Priolkar R.N.S., Biradar B., Mamledesai1 S. Synthesis of 4-hydroxy-1-(phenyl/methyl)-3-[3-(substituted amino)-2-nitropropanoyl] quinolin-2(1H)-ones as an antimicrobial andantitubercular agents. Indian J. Heterocycl. Chem. 2017;27:223\u2013228."}, {"Citation": "Sharifi-Rad J., Sureda A., Tenore G.C., Daglia M., Sharifi-Rad M., Valussi M., Tundis R., Sharifi-Rad M., Loizzo M.R., Ademiluyi A.O., et al. Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems. Molecules. 2017;22:70. doi: 10.3390/molecules22010070.", "ArticleIdList": ["10.3390/molecules22010070", "PMC6155610", "28045446"]}, {"Citation": "Dosoky N.S., Setzer W.N. Maternal Reproductive Toxicity of Some Essential Oils and Their Constituents. Int. J. Mol. Sci. 2021;22:2380. doi: 10.3390/ijms22052380.", "ArticleIdList": ["10.3390/ijms22052380", "PMC7956842", "33673548"]}, {"Citation": "Conlon P.M., Haack K.M., Rodgers N.J., Dion L.J., Cambern K.L., Rohlik G.M., Nelson D.E., Barry T.A., Ayres S.J., Cutshall S.M. Introducing Essential Oils into Pediatric and Other Practices at an Academic Medical Center. J. Holist. Nurs. 2017;35:389\u2013396. doi: 10.1177/0898010116677400.", "ArticleIdList": ["10.1177/0898010116677400", "27837082"]}, {"Citation": "de Matos S.P., Teixeira H.F., de Lima A.A.N., Veiga-Junior V.F., Koester L.S. Essential Oils and Isolated Terpenes in Nanosystems Designed for Topical Administration: A Review. Biomolecules. 2019;9:138. doi: 10.3390/biom9040138.", "ArticleIdList": ["10.3390/biom9040138", "PMC6523335", "30959802"]}, {"Citation": "Sapra B., Jain S., Tiwary A.K. Percutaneous permeation enhancement by terpenes: Mechanistic view. AAPS J. 2008;10:120\u2013132. doi: 10.1208/s12248-008-9012-0.", "ArticleIdList": ["10.1208/s12248-008-9012-0", "PMC2751457", "18446512"]}, {"Citation": "Lalko J., Api A.M. Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay. Food Chem. Toxicol. 2006;44:739\u2013746. doi: 10.1016/j.fct.2005.10.006.", "ArticleIdList": ["10.1016/j.fct.2005.10.006", "16324777"]}, {"Citation": "Opdyke D.L.J. Inhibition of sensitization reactions induced by certain aldehydes. Food Cosmet. Toxicol. 1976;14:197\u2013198. doi: 10.1016/S0015-6264(76)80424-5.", "ArticleIdList": ["10.1016/S0015-6264(76)80424-5", "950213"]}, {"Citation": "Nilsson A.M., Gafvert E., Salvador L., Luthman K., Bruze M., Gruvberger B., Nilsson J.L., Karlberg A.T. Mechanism of the antigen formation of carvone and related alpha, beta-unsaturated ketones. Contact Dermat. 2001;44:347\u2013356. doi: 10.1034/j.1600-0536.2001.044006347.x.", "ArticleIdList": ["10.1034/j.1600-0536.2001.044006347.x", "11380545"]}, {"Citation": "Nilsson A.M., Jonsson C., Luthman K., Nilsson J.L., Karlberg A.T. Inhibition of the sensitizing effect of carvone by the addition of non-allergenic compounds. Acta Derm. Venereol. 2004;84:99\u2013105. doi: 10.1080/00015550310006770.", "ArticleIdList": ["10.1080/00015550310006770", "15206687"]}, {"Citation": "Karlberg A.T., Nilsson A.M., Luthman K., Nilsson J.L. Structural analogues inhibit the sensitizing capacity of carvone. Acta Derm. Venereol. 2001;81:398\u2013402. doi: 10.1080/000155501317208318.", "ArticleIdList": ["10.1080/000155501317208318", "11859940"]}, {"Citation": "Basketter D. Quenching: Fact or fiction? Contact Dermat. 2000;43:253\u2013258. doi: 10.1034/j.1600-0536.2000.043005253.x.", "ArticleIdList": ["10.1034/j.1600-0536.2000.043005253.x", "11016664"]}, {"Citation": "Marturano V., Bizzarro V., De Luise A., Calarco A., Ambrogi V., Giamberini M., Tylkowski B., Cerruti P. Essential oils as solvents and core materials for the preparation of photo-responsive polymer nanocapsules. Nano Res. 2018;11:2783\u20132795. doi: 10.1007/s12274-017-1908-5.", "ArticleIdList": ["10.1007/s12274-017-1908-5"]}, {"Citation": "Mashwani Z.U., Khan M.A., Khan T., Nadhman A. Applications of plant terpenoids in the synthesis of colloidal silver nanoparticles. Adv. Colloid Interface Sci. 2016;234:132\u2013141. doi: 10.1016/j.cis.2016.04.008.", "ArticleIdList": ["10.1016/j.cis.2016.04.008", "27181393"]}, {"Citation": "Perino-Issartier S., Ginies C., Cravotto G., Chemat F. A comparison of essential oils obtained from lavandin via different extraction processes: Ultrasound, microwave, turbohydrodistillation, steam and hydrodistillation. J. Chromatogr. A. 2013;1305:41\u201347. doi: 10.1016/j.chroma.2013.07.024.", "ArticleIdList": ["10.1016/j.chroma.2013.07.024", "23890545"]}, {"Citation": "Anastas P.T., Kirchhoff M.M. Origins, current status, and future challenges of green chemistry. Acc. Chem. Res. 2002;35:686\u2013694. doi: 10.1021/ar010065m.", "ArticleIdList": ["10.1021/ar010065m", "12234198"]}, {"Citation": "Tucker J.L. Green Chemistry, a Pharmaceutical Perspective. Org. Process. Res. Dev. 2006;10:315\u2013319. doi: 10.1021/op050227k.", "ArticleIdList": ["10.1021/op050227k"]}, {"Citation": "Patel K.D., Davison J.S., Pittman Q.J., Sharkey K.A. Cannabinoid CB(2) receptors in health and disease. Curr. Med. Chem. 2010;17:1393\u20131410. doi: 10.2174/092986710790980041.", "ArticleIdList": ["10.2174/092986710790980041", "20166925"]}, {"Citation": "Cassano T., Calcagnini S., Pace L., De Marco F., Romano A., Gaetani S. Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target. Front. Neurosci. 2017;11:30. doi: 10.3389/fnins.2017.00030.", "ArticleIdList": ["10.3389/fnins.2017.00030", "PMC5288380", "28210207"]}, {"Citation": "Ramirez B.G., Blazquez C., Gomez del Pulgar T., Guzman M., de Ceballos M.L. Prevention of Alzheimer\u2019s disease pathology by cannabinoids: Neuroprotection mediated by blockade of microglial activation. J. Neurosci. 2005;25:1904\u20131913. doi: 10.1523/JNEUROSCI.4540-04.2005.", "ArticleIdList": ["10.1523/JNEUROSCI.4540-04.2005", "PMC6726060", "15728830"]}, {"Citation": "Farooqui A.A. Molecular Mechanisms of Dementia. Academic Press; Cambridge, MA, USA: 2019. Potential Treatment Strategies for the Treatment of Dementia With Chinese Medicinal Plants; pp. 251\u2013286."}, {"Citation": "Koppel J., Bradshaw H., Goldberg T.E., Khalili H., Marambaud P., Walker M.J., Pazos M., Gordon M.L., Christen E., Davies P. Endocannabinoids in Alzheimer\u2019s disease and their impact on normative cognitive performance: A case-control and cohort study. Lipids Health Dis. 2009;8:2. doi: 10.1186/1476-511X-8-2.", "ArticleIdList": ["10.1186/1476-511X-8-2", "PMC2631501", "19144193"]}, {"Citation": "Sharma C., Sadek B., Goyal S.N., Sinha S., Kamal M.A., Ojha S. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development. Evid. Based Complementary Altern. Med. 2015;2015:238482. doi: 10.1155/2015/238482.", "ArticleIdList": ["10.1155/2015/238482", "PMC4664820", "26664449"]}, {"Citation": "Gulluni N., Re T., Loiacono I., Lanzo G., Gori L., Macchi C., Epifani F., Bragazzi N., Firenzuoli F. Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects. Evid. Based Complementary Altern. Med. 2018;2018:1709182. doi: 10.1155/2018/1709182.", "ArticleIdList": ["10.1155/2018/1709182", "PMC5822802", "29576792"]}, {"Citation": "Pacher P., Kunos G. Modulating the endocannabinoid system in human health and disease--successes and failures. FEBS J. 2013;280:1918\u20131943. doi: 10.1111/febs.12260.", "ArticleIdList": ["10.1111/febs.12260", "PMC3684164", "23551849"]}, {"Citation": "Shepard B.D., Pluznick J.L. How does your kidney smell? Emerging roles for olfactory receptors in renal function. Pediatric Nephrol. 2016;31:715\u2013723. doi: 10.1007/s00467-015-3181-8.", "ArticleIdList": ["10.1007/s00467-015-3181-8", "PMC4752438", "26264790"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "29"}, {"Year": "2021", "Month": "12", "Day": "15"}, {"Year": "2021", "Month": "12", "Day": "19"}, {"Year": "2022", "Month": "1", "Day": "11", "Hour": "1", "Minute": "5"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "12", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["35009027", "PMC8747111", "10.3390/plants11010021", "plants11010021"]}}], "PubmedBookArticle": []}